4-Octyl itaconate inhibits vascular calcification partially via modulation of HMOX-1 signaling
- 10 November 2024
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 985, 177122
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82370418)
- Basic and Applied Basic Research Foundation of Guangdong Province (2024A1515010559, 2024A1515012864, 2024A1515012912)
This publication has 55 references indexed in Scilit:
- Endogenously produced itaconate negatively regulates innate-driven cytokine production and drives global ubiquitination in human macrophagesCell Reports, 2024
- Wogonin inhibits oxidative stress and vascular calcification via modulation of heme oxygenase-1European Journal of Pharmacology, 2023
- Itaconate: A promising precursor for treatment of neuroinflammation associated depressionBiomedicine & Pharmacotherapy, 2023
- Abietic acid inhibits acetaminophen-induced liver injury by alleviating inflammation and ferroptosis through regulating Nrf2/HO-1 axisInternational Immunopharmacology, 2023
- Modulation of the Itaconate Pathway Attenuates Murine LupusArthritis & Rheumatology, 2022
- Downregulation of HDAC9 by the ketone metabolite β‐hydroxybutyrate suppresses vascular calcificationThe Journal of Pathology, 2022
- Up-regulation of heme oxygenase-1 by celastrol alleviates oxidative stress and vascular calcification in chronic kidney diseaseFree Radical Biology and Medicine, 2021
- Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing HemodialysisJAMA, 2021
- The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome ActivationCell Metabolism, 2020
- Inflammation: a culprit for vascular calcification in atherosclerosis and diabetesCellular and Molecular Life Sciences, 2015